Access links:
CONTENT
Destacados
News
- 09/01/2012
IrsiCaixa describes new natural HIV-controlling mechanisms that the AIDS vaccine will have to induce
- The IrsiCaixa Aids Research Institute, jointly promoted by the “la Caixa” Foundation and the Health Department of the Generalitat de Catalonia, has described some very effective...
- 01/12/2011
IrsiCaixa and “la Caixa” Foundation launch a scientific dissemination and prevention program on AIDS for young people, which contributes to a reduced risk of infection
The IrsiCaixa AIDS Research Institute is presenting, together with “la Caixa” Foundation, a scientific dissemination and prevention program on AIDS aimed at secondary school students, which is...
- 22/09/2011
HIVACAT to host the AIDS Vaccine 2013, the most prestigious international congress that focuses on AIDS vaccine research
The Catalan Program for AIDS Vaccine Research, HIVACAT, has been selected to host AIDS Vaccine 2013, the largest and most prestigious international congress focusing exclusively on HIV vaccine...
- 21/09/2011
IrsiCaixa, the Autonomous University of Barcelona and Harvard University set up a pioneer postgraduate programme in AIDS
The IrsiCaixa Institute for AIDS Research and the Autonomous University of Barcelona (UAB) have reached an agreement to cooperate with Harvard University Medical School of Boston, the Harvard...
- 19/09/2011
HIVACAT identifies candidate to HIV vaccine and initiates animal experimentation
HIVACAT has identified several protein fragments with high potential to stimulate an effective immune response against HIV.This finding has required studies in over 1,000 patients and has allowed...
- 15/06/2011
Scientists identify 6 key genes that will predict the course of the AIDS virus infection in each patient
IrsiCaixa researchers have analyzed the complete genome of more than 60 people infected with the AIDS virus and have identified 6 key genes that predict how the infection will progress in each...
- 18/05/2011
HIVACAT identifies a therapy that makes vaccines that did not work in HIV-infected patients effective
Researchers from the IrsiCaixa Institute for AIDS Research, driven by the Social Program of "la Caixa" Foundation and the Department of Health of the Generalitat de Catalunya, have identified a...
- 27/04/2011
12% of children with HIV develop a triple virologic failure
A study published in the online edition of the journal The Lancet finds that 12% of children with HIV in Europe develop a triple virological failure. The study, led by the Medical Research Council...
- 06/04/2011
The presence of drug-resistant HIV minority variants doubles the risk of virologic failure in patients
Researchers at IrsiCaixa AIDS Research Institute participated in a study showing that some HIV-positive people have drug-resistant HIV minority variants which are not detectable with regular...
- 09/03/2011
IrsiCaixa collaborates with the training of researchers in South Africa
Normal 0 21 false false false MicrosoftInternetExplorer4 Researcher Julia G Prado travels to the city of Durban to apply current knowledge on HIV to virus subtype C IrsiCaixa’s...
